Diclofenac
Acts through cyclo-oxygenase-2 (COX-2) inhibition, striking inflammation at its source
Learn how diclofenac reduces inflammation by inhibiting prostaglandin biosynthesis through action on the COX enzymes with selectivity for COX-2, and inhibiting phospholipase A2 activity to reduce the production of inflammatory leukotrienes.1,2,4
![Voltaren Emulgel with superior pain relief and rapid joint function improvement compared to oral Naproxen](https://i-cf65.ch-static.com/content/dam/cf-consumer-healthcare/health-professionals/en_SA/pain-relief/voltaren/IMAGE%20NO%20(5)%20970-416%20px.jpg?auto=format)
Diclofenac is a potent anti-inflammatory agent1
Its effect on the COX-2 enzyme means that, unlike non-NSAID medications such as paracetamol, diclofenac not only provides pain relief but also treats inflammation – a root cause of pain.2,4
Diclofenac, an NSAID (and therefore in the same drug class as Naproxen ), shows marked potency in its inhibition of the COX-2 enzyme.5
Diclofenac targets inflammation to strike pain at its source
Diclofenac-containing product
![Voltaren Triple Effect 1.16% Emulgel](https://i-cf65.ch-static.com/content/dam/cf-consumer-healthcare/health-professionals/en_SA/pain-relief/Voltaren%20pack%20shot%20750x421pix01.jpg?auto=format)
Voltaren Triple Effect 1.16% Emulgel
Voltaren Triple Effect 1.16% Emulgel contains 1.16% diclofenac diethylamine and is an effective alternative to over-the-counter oral analgesics.2,6,7
Indicated for relief of pain and swelling in soft-tissue injuries and localised forms of soft-tissue rheumatism, and relief of non-serious arthritis of the knee or fingers.2
Diclofenac – a potent anti-inflammatory ingredient1
![Voltaren emulgel pack shot](https://i-cf65.ch-static.com/content/dam/cf-consumer-healthcare/health-professionals/en_SA/pain-relief/Voltaren%20pack%20shot%20750x421pix01.jpg?auto=format)
Voltaren Emulgel product
Learn more about Voltaren Emulgel product that contain this potent anti-inflammatory ingredient.1
![Leaflet icon](https://i-cf65.ch-static.com/content/dam/cf-consumer-healthcare/health-professionals/en_SA/icons/GEP404_Rapid_Relief_Leaflet_Icon.png?auto=format)
Voltaren Triple Effect Emulgel Clinical Summaries
This clinical summary assesses DDEA 1.16% gel compared with placebo gel in acute NP.
![Educational resources](https://i-cf65.ch-static.com/content/dam/cf-consumer-healthcare/health-professionals/en_SA/icons/GSK_GEP_Educate_Icon.png?auto=format)